Detection of Chromosome 13q Deletions and IgH Translocations in Patients with Multiple Myeloma by FISH: Comparison with Karyotype Analysis

References

• Bataill, R. and Harousseau, J.L. (1997) "Multiple myeloma", New England Journal of Medicine, 336, 1657–1664.
   Web of Science ®Google Scholar
• Greenlee, R.T., Murray, T., Bolden, S. and Wingo, P.A. (2000) "Cancer statistics, 2000", Ca: a Cancer Journal for Clinicians, 50, 7–33.
   PubMed Web of Science ®Google Scholar
• Trico, G., Sawyer, J., Jagannath, S., Desikan, KR., Siegel, D., Naucke, S., et al. (1997) "Unique role of cytogenetics in the prognosis of patients with myeloma receiving high-dose therapy and autotransplants", Journal of Clinical Oncology, 15, 2659–2666.
   Google Scholar
• Seong, C., Delasalle, K., Hayes, D., Dimopoulos, M., Swantkowski, J., Huh, Y., et al. (1998) "Prognostic value of cytogenetics in multiple myeloma", British Journal of Haematol, 101, 189–194.
   PubMed Web of Science ®Google Scholar
• Konigsberg, R., Zojer, N., Ackermann, J., Kromer, E., Kittler, H., Fritz, E., et al. (2000) "Predictive role of interphase cytogenetics for survival of patients with multiple myeloma", Journal of Clinical Oncology, 18, 804–812.
   Google Scholar
• Bergsagel, P.L., Chesi, M., Nardini, E., Brents, L.A., Kirby, S.L. and Kuehl, W.M. (1996) "Promiscuous translocation into immu-noglobulin heavy chain switch regions in multiple myelomas", Proceedings of the National Academy of Sciences USA, 93, 13931–13936.
   Google Scholar
• Bergsagel, P.L. and Kuehl, W.M. (2001) "Chromosome transloca-tions in multiple myeloma", Oncogene, 20, 5611–5622.
   Google Scholar
• Avet-Loiseau, H., Li, J.Y., Facon, T., Brigaudeau, C., Morineau, N., Maloisel, F., et al. (1998) "High incidence of translocations t(11;14)(q13;q32) and t(4;14)(p16;q32) in patients with plasma cell malignancies", Cancer Research, 58, 5640–5645.
   PubMed Web of Science ®Google Scholar
• Avet-Loiseau, H., Brigaudeau, C., Talmant, P., Lai, J.L., Daviet, A., Li, J.Y., et al. (1999) "High incidence of cryptic translocations involving the Ig heavy chain gene in multiple myeloma, as shown by fluorescence in situ hybridization", Genes, Chromosomes and Cancer, 24, 9–15.
   Google Scholar
• Chesi, M., Bergsagel, P.L., Brents, L.A., Smith, CM., Gerhard, D.S. and Kuehl, W.M. (1996) "Dysregulation of cyclin DI by translocation into an IgH gamma switch region in two multiple myeloma cell lines", Blood, 88, 674–681.
   Google Scholar
• Chesi, M., Nardini, E., Brents, L.A., Schrock, E., Ried, T., Kuehl, W.M. et al. (1997) "Frequent translocation t(4;14)(p16.3;q32.3) in multiple myeloma is associated with increased expression and activating mutations of fibroblast growth factor receptor 3", Nature Genetics, 16, 260–264.
   PubMed Web of Science ®Google Scholar
• Chesi, M., Bergsgel, P.L., Shonukan, O.O., Martelli, ML., Brents, L.A., Chen, T., et al. (1998) "Frequent dysregulation of the c-maf proto-oncogene at 16q23 by translocation to an IgG locus in multiple myeloma", Blood, 91, 4457–4463.
   PubMed Web of Science ®Google Scholar
• Hanamura, I., Iida, S., Akano, Y., Hayami, Y., Kaot, M., Miura, K., et al. (2001) "Ectopic expression of math gene in human myeloma cells carrying t(14;20(q32;q11) chromosomal transloca-tions", Japanese Journal of Cancer Research, 92, 638–644.
   PubMedGoogle Scholar
• Shou, Y., Martelli, ML., Gabrea, A., Qi, Y., Brents, L.A., Roschke, A., et al. (2000) "Diverse karyotypic abnormalities of c-myc locus associated with c-myc dysregulation and tumor progression in multiple myeloma", Proceedings of the National Academy of Sciences USA, 97, 228–233.
   Google Scholar
• Drach, J., Ackermann, J., Fritz, E., Kromer, E., Schuster, R., Gisslinger, H., et al. (1998) "Presence of a p53 deletion in patients with multiple myeloma predicts for short survival after conven-tional-dose chemotherapy", Blood, 92, 802–809.
   PubMed Web of Science ®Google Scholar
• Hallek, M., Bergsagel, P.L. and Anderson, K.C. (1998) "Multiple myeloma: increasing evidence for a multistep transformation process", Blood, 91, 3 — 21.
   Google Scholar
• Avet-Loiseau, H., Facon, T., Grobois, B., Magrangeas, F., Rapp, M.J., Harousseau, J.L., et al. Intergroupe Francophone du Myelome. (2002) "Oncogenesis of multiple myeloma:14q32 and 13q chromosomal abnormalities are not randomly distributed, but correlate with natural history, immunological features, and clinical presentation", Blood, 99, 2185–2191.
   PubMed Web of Science ®Google Scholar
• Fonseca, R., Blood, E.A., Oken, M.M., Kyle, R.A., Dewald, G.W., Bailey, R.J., et al. (2002) "Myeloma and the t(11;14)(q13;q32); evidence for a biologically defined unique subset of patients", Blood, 99, 3735–3741.
   PubMed Web of Science ®Google Scholar
• Moreau, P., Facon, T., Leleu, X., Morineau, N., Huyghe, P., Harousseau, J.L., et al. Intergroupe Francophone du Myelome. (2002) "Recurrent 14q32 translocations determine the prognosis of multiple myeloma, especially in patients receiving intensive che-motherapy", Blood, 100, 1579 — 1583.
   Google Scholar
• Smadja, N.Y., Bastard, C., Brigaudeau, C., Leroux, D. and Fruchart, C. (2001) "Hypodiploidy is a major prognostic factor in multiple myeloma", Blood, 98, 2229–2238.
   Google Scholar
• Debes-Marun, CS., Dewald, G.W., Bryant, S., Picken, E., Santana-Davila, R., Gonzalez-Paz, N., et al. (2003) "Chromosome abnorm-alities clustering and its implications for pathogenesis and prognosis in myeloma", Leukemia, 17, 427–436.
   Google Scholar
• Chang, H., Bouman, D., Boerkoel, C.F., Stewart, AK. and Squire, J.A. (1999) "Frequent monoallelic loss of D135319 in multiple myeloma patients shown by interphase fluorescence in situ hybridization", Leukemia, 13, 105 — 109.
   Google Scholar
• Avet-Loiseau, H., Li, J.Y., Morineau, N., Facon, T., Brigaudeau, C., Harousseau, J.L., et al. (1999) "Monosomy 13 is associated with the transition of monoclonal gammopathy of undetermined significance to multiple myeloma. Intergroupe Francophone du Myeloma", Blood, 94, 2583–2589.
   Google Scholar
• Zojer, N., Konigsberg, R., Ackmann, J., Fritz, E., Dallinger, S., Kromer, E., et al. (2000) "Deletion of 13q14 remains an independent adverse prognostic variable in multiple myeloma despite its frequent detection by interphase fluorescence in situ hybridization", Blood, 95, 1925–1930.
   Google Scholar
• Facon, T., Avet-Loiseau, H., Guillerm, G., Moreau, P., Genevieve, R., Zandecki, M., et al. Intergroupe Francophone du Myeloma. (2001) "Chromosome 13 abnormalities identified by FISH analysis and serum beta-2 microglobulin produce a powerful myeloma staging system for patients receiving high-dose therapy", Blood, 97, 1566–1571.
   PubMed Web of Science ®Google Scholar
• Fonseca, R., Harrington, D., Oken, MM., Dewald, GW., Bailey, R.J., Van Wier, S.A., et al. (2002) "Biological and prognostic significance of interphase fluorescence in situ hybridization detec-tion of chromosome 13 abnormalities (delta 13) in multiple myeloma: an eastern cooperative oncology group study", Cancer Research, 62, 715 — 720.
   Google Scholar
• Harrison, C.J., Mazzullo, H., Cheung, K.L., Gerrard, G., Jalali, G.R., Mehta, A., et al. (2003) "Cytogenetics of multiple myeloma: interpretation of fluorescence in situ hybridization results", British Journal of Haematology, 120, 944–952.
   Google Scholar
• Ahmann, G.J., Jalal, S.M., Juneau, A.L., Christensen, E.R., Hanson, C.A., Dewald, G.W., et al. (1998) "A novel three-color, clone-specific fluorescence in situ hybridization procedure for monoclonal gammopathies", Cancer Genetics and Cytogenetics, 101, 7–11.
   Google Scholar
• Fonseca, R., Oken, M.M. and Greipp, P.R. (2001) "The t(4;14)(p16.3;q32) is strongly associated with chromosome 13 abnormalities in both multiple myeloma and monoclonal gammo-pathy of undetermined significance", Blood, 98, 1271–1272.
   PubMed Web of Science ®Google Scholar